Chemical Compound Review:
Frovelan (6R)-6-methylamino-6,7,8,9- tetrahydro-5H...
Synonyms:
Allegro, Auradol, Miguard, Rilamig, Migard, ...
Tfelt-Hansen,
De Vries,
Saxena,
Adelman,
Lewit,
Mucke,
Khan,
Viswanathan,
Rao,
Reddy,
Siow,
Pozo-Rosich,
Silberstein,
Goldstein,
- Frovatriptan for the treatment of cluster headaches. Siow, H.C., Pozo-Rosich, P., Silberstein, S.D. Cephalalgia : an international journal of headache. (2004)
- Frovatriptan for the acute treatment of migraine: a dose-finding study. Goldstein, J., Keywood, C. Headache. (2002)
- Frovatriptan use in migraineurs with or at high risk of coronary artery disease. Elkind, A.H., Satin, L.Z., Nila, A., Keywood, C. Headache. (2004)
- Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials. Poolsup, N., Leelasangaluk, V., Jittangtrong, J., Rithlamlert, C., Ratanapantamanee, N., Khanthong, M. Journal of clinical pharmacy and therapeutics. (2005)
- Effects of the novel antimigraine agent, frovatriptan, on coronary and cardiac function in dogs. Parsons, A.A., Valocik, R., Koster, P., Raval, P., Gagnon, R., Tilford, N., Feuerstein, G. J. Cardiovasc. Pharmacol. (1998)
- Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Tfelt-Hansen, P., De Vries, P., Saxena, P.R. Drugs (2000)
- Pharmacokinetics of frovatriptan in adolescent migraineurs. Elkind, A.H., Wade, A., Ishkanian, G. Journal of clinical pharmacology. (2004)
- Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Géraud, G., Spierings, E.L., Keywood, C. Headache. (2002)
- Comparative aspects of triptans in treating migraine. Adelman, J.U., Lewit, E.J. Clinical cornerstone. (2001)
- Frovatriptan: a review. Goldstein, J. Expert opinion on pharmacotherapy. (2003)
- Clinical pharmacokinetics of frovatriptan. Buchan, P., Keywood, C., Wade, A., Ward, C. Headache. (2002)
- Pharmacology of the selective 5-HT(1B/1D) agonist frovatriptan. Comer, M.B. Headache. (2002)
- Clinical efficacy of frovatriptan: placebo-controlled studies. Ryan, R., Géraud, G., Goldstein, J., Cady, R., Keywood, C. Headache. (2002)
- Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogs. Parsons, A.A., Parker, S.G., Raval, P., Campbell, C.A., Lewis, V.A., Griffiths, R., Hunter, A.J., Hamilton, T.C., King, F.D. J. Cardiovasc. Pharmacol. (1997)
- Frovatriptan: a review of drug-drug interactions. Buchan, P., Wade, A., Ward, C., Oliver, S.D., Stewart, A.J., Freestone, S. Headache. (2002)
- Effects of the novel high-affinity 5-HT(1B/1D)-receptor ligand frovatriptan in human isolated basilar and coronary arteries. Parsons, A.A., Raval, P., Smith, S., Tilford, N., King, F.D., Kaumann, A.J., Hunter, J. J. Cardiovasc. Pharmacol. (1998)
- Frovatriptan: a selective type 1B/1D serotonin receptor agonist for the treatment of migraine headache. Cole, P., Rabasseda, X. Drugs of today (Barcelona, Spain : 1998) (2002)
- Frovatriptan Vernalis. Mucke, H.A. Current opinion in investigational drugs (London, England : 2000) (2002)
- Chiral separation of Frovatriptan isomers by HPLC using amylose based chiral stationary phase. Khan, M., Viswanathan, B., Rao, D.S., Reddy, R. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2007)